UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2601-2608

2012

Volltextzugriff (PDF)

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up

Acta oncologica, 2024-07, Vol.63 (1), p.535-541

2024

Volltextzugriff (PDF)

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.397-406

2013

Volltextzugriff (PDF)

PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer

Clinical cancer research, 2007-06, Vol.13 (12), p.3577-3584

2007

Volltextzugriff (PDF)

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.553-561

2011

Volltextzugriff (PDF)

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R953-R964, Article R953

2005

Volltextzugriff (PDF)

Breast Cancer Survival Defined by Biological Receptor and Menopausal Status in Vietnamese Women

Cancer control, 2019-01, Vol.26 (1), p.1073274819865279-1073274819865279

2019

Volltextzugriff (PDF)

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

Breast cancer research : BCR, 2005-01, Vol.7 (3), p.R284-R290, Article R284

2005

Volltextzugriff (PDF)

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

Breast cancer research and treatment, 2011-04, Vol.126 (2), p.421-430

2011

Volltextzugriff (PDF)

A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research

Acta cytologica, 2017, Vol.61 (4-5), p.305-315

2017

Volltextzugriff (PDF)

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer

Radiotherapy and oncology, 2007-09, Vol.84 (3), p.242-251

2007

Volltextzugriff (PDF)

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer

PloS one, 2012, Vol.7 (7), p.e40568-e40568

2012

Volltextzugriff (PDF)

Akt kinases in breast cancer and the results of adjuvant therapy

Breast cancer research : BCR, 2003-01, Vol.5 (2), p.R37-R44, Article R37

2003

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.457-465

2011

Volltextzugriff (PDF)

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

Clinical cancer research, 2009-05, Vol.15 (10), p.3610-3616

2009

Volltextzugriff (PDF)

Intact Mre11/Rad50/Nbs1 Complex Predicts Good Response to Radiotherapy in Early Breast Cancer

International journal of radiation oncology, biology, physics, 2007-05, Vol.68 (1), p.50-58

2007

Volltextzugriff (PDF)

Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients

Journal of Analytical Oncology, 2015-03, Vol.4 (2)

2015

Volltextzugriff (PDF)

Expression of the CD117, COX-2 and HSP90 Antigens and Cell Proliferation in Fine-needle-aspirated Cells from Metastatic Melanomas

Anticancer research, 2009-11, Vol.29 (11), p.4345-4352

2009

Volltextzugriff (PDF)

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

BMC medicine, 2006-06, Vol.4 (1), p.16-16, Article 16

2006

Volltextzugriff (PDF)

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4071-4082

2022

Volltextzugriff (PDF)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

British journal of cancer, 2011-05, Vol.104 (11), p.1762-1769

2011

Volltextzugriff (PDF)

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.313-322

2016

Volltextzugriff (PDF)

Immune gene expression and response to chemotherapy in advanced breast cancer

British journal of cancer, 2018-02, Vol.118 (4), p.480-488

2018

Volltextzugriff (PDF)

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

Annals of oncology, 2015-01, Vol.26 (1), p.81-88

2015

Volltextzugriff (PDF)

Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer

Clinical cancer research, 2016-01, Vol.22 (1), p.146-157

2016

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Breast Cancer Survival Defined by Biological Receptor and Menopausal Status in Vietnamese Women

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research

The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer

Akt kinases in breast cancer and the results of adjuvant therapy

Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

Intact Mre11/Rad50/Nbs1 Complex Predicts Good Response to Radiotherapy in Early Breast Cancer

Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients

Expression of the CD117, COX-2 and HSP90 Antigens and Cell Proliferation in Fine-needle-aspirated Cells from Metastatic Melanomas

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer

Immune gene expression and response to chemotherapy in advanced breast cancer

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer

Suchergebnisse filtern